Among the 1,575 patients with MFS and FBN1 gene mutation referred to the French reference center during the study period, 19 (1.2%) patients were operated for 25 non-dissecting DAPA and accounted for the study group. The gene discussed is FBN1; the disease is Marfan syndrome.